普鲁卡因（杰诺维塔）：对背部或髋部疾病患者的康复结果无影响。
Procaine (Gerovital): no effect on the rehabilitation result in patients with back or hip disease.
作者信息
Rissanen V, Rissanen P, Tuomisto J
机构信息
Siilinjärvi Rehabilitation Centre, Finland.
出版信息
Ann Med. 1990 Jun;22(3):151-6. doi: 10.3109/07853899009147260.
Gerovital was compared with placebo and another procaine preparation in a double blind study of 88 rehabilitation patients suffering from back or hip disease. In an open part of the study procaine from intramuscularly injected Gerovital disappeared from the plasma within 15-30 minutes. In patients treated with Gerovital or another procaine no clinical, physiological or psychological benefits were found in addition to the improvements following rehabilitation compared with placebo treatment. Clinical examination showed that the benefits of rehabilitation were similar in patients receiving Gerovital, another procaine and placebo.
在一项针对88名患有背部或髋部疾病的康复患者的双盲研究中，将益康宁与安慰剂及另一种普鲁卡因制剂进行了比较。在该研究的开放部分，肌肉注射益康宁中的普鲁卡因在15 - 30分钟内从血浆中消失。与安慰剂治疗相比，接受益康宁或另一种普鲁卡因治疗的患者，除了康复带来的改善外，未发现临床、生理或心理方面的益处。临床检查表明，接受益康宁、另一种普鲁卡因和安慰剂治疗的患者，康复效果相似。
Zotero 插件